Superiority
1, has Oxandrol Anavar a high quality with competitive price
(1)Standard: Enterprise Standard
(2)All Purity≥ 99%
(3)We are manufacturer and can provide high quality products with factory price.
2, Fast and safe delivery
(1)Parcel can be sent out in 24 hours after payment. Tracking number available
(2)Secure and discreet shipment.Various transportation methods for your choice.
(3)Customs pass rate ≥ 99%
(4) We have our own agent/remailer/distributor who can help us ship our products very fast and safe,
and we have stock in there for transferring.
3, We have clients throughout the world.
(1)Professional service and rich experience make customers feel at ease, adequate stock and fast
delivery meet their desire.
(2)Market feedback and goods feedback will be appreciated, meeting customer's requirement is our responsibility.
(3) High quality, competitive price, fast delivery, first-class service gain the trust and praise from the customers.
Details
USP Pharma Grade 99% Pharmaceutical powder Hydroxyurea for anti cancer
Product Name |
Hydroxyurea
|
Synonyms |
biosupressin;carbamohydroxamicacid;
|
CAS |
127-07-1
|
MF |
CH4N2O2
|
MW |
76.05
|
EINECS |
204-821-7
|
Purity |
99%
|
Appearance |
Off-White Crystalline Solid
|
Certification |
ISO 9001, USP, BP
|
Grade |
Pharma Grade
|
Usage |
An anti-neoplastic - inhibits ribonucleoside reductase and
DNA replication.
|
Packing |
Discreet packing ways as your requirement, 100% go through
|
Storage |
Store in cool and dry area and keep away from direct sunlight
|
Description and Application:
Hydroxyurea is a kind of anti-cancer drug for the treatment of chronic myeloid leukemia. At as early as the 1920s, it had been observed that hydroxyurea can cause the rabbits to produce megaloblastic cell similar as pernicious anemia and can inhibit leukocyte generation. Hydroxyurea can induce bacteria to produce a toxic molecule itself to achieve the purpose of killing bacteria.
Hydroxy urea is a kind of nucleoside diphosphate reductase inhibitor and can inhibit the reduction from nucleotide to deoxynucleotide, interfering with the biosynthesis of purine and pyrimidine bases and selectively blocking the DNA synthesis. It can also cause partial inhibition of the conversion of ribonucleotides into deoxyribonucleotides. However, it has no blocking effect on RNA and protein synthesis. Hydroxyurea belongs to cycle specific drugs and is sensitive to S phase cell and can induce the hematologic remission of chronic myeloid leukemia. Compared with an alkylating agent busulfan and melphalan, it causes low incidence of secondary leukemia. The myelosuppressive effects of hydroxyurea will last for several days to several weeks which is easier to control compared with the alkylating agent. Clinically hydroxyurea is suitable or the treatment of chronic myeloid leukemia, acute lymphocytic and acute non-lymphocytic leukemia accompanied with high cell count, idiopathic thrombocythemia, polycythemia vera, prevention of retinoic acid syndrome in acute myeloid leukemia and treatment of sickle cell anemia with frequent episodes of pain. In addition, hydroxyurea have a certain effect on the treatment of head and neck cancer, recurrent metastatic ovarian cancer, renal cancer and so on.
Uses:
It belongs to anti-metabolic anti-cancer drugs with its major role in the proliferation of cells in G1 and S phase. It also had delayed effect on G1/S interface. It is a cell-specific drug.
It can be applied to biochemical studies.
Through the formation of free nitric oxide, it binds to the tyrosine of the enzyme active site, leaving the nucleoside reductase inactivated. This hampers the synthesis of deoxynucleotide. It is clinically used for the treatment of chronic myelogenous leukemia as well as being used to treat metastatic ovarian cancer, head and neck primary squamous cell carcinoma and intractable psoriasis. The good belongs to anticancer drugs.
Usage:
An anti-neoplastic - inhibits ribonucleoside reductase and DNA replication. A potential therapy for sickle cell anemia which involves the nitrosylation of sickle cell hemoglobin. Horseradish peroxidase catalyzes nitric oxide formation from hydroxyurea in the presence of hydrogen peroxide.